Jyong Biotech Ltd.
MENS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001954488
No open-market purchases or sales by Jyong Biotech Ltd. insiders were filed in the last 90 days; 19 institutions reported holding it in 13F filings for Q2 2026, worth $1.01M in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, +2 vs. previous quarter
- 19
- 13F valueReported value at the end of Q2 2026
- $1.01M
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding MENS, Q2 2026
No superinvestor reported holding MENS at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Jyong Biotech Ltd. insiders from Form 4, newest first.
No open-market purchases or sales by Jyong Biotech Ltd. insiders are on file.
Top 10 13F holders, Q2 2026
The largest institutional positions in Jyong Biotech Ltd. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock, Inc. | 260,317 | $538.9K | 0.00% | +1,557+0.6% | Added |
| Geode Capital Management, LLC | 68,882 | $142.6K | 0.00% | +4,650+7.2% | Added |
| HRT Financial LP | 50,423 | $104.0K | 0.00% | +38,656+328.5% | Added |
| XTX Topco Ltd | 29,066 | $60.2K | 0.00% | +29,066 | New |
| Renaissance Technologies LLC | 22,900 | $47.4K | 0.00% | +22,900 | New |
| China Universal Asset Management Co., Ltd. | 12,100 | $25.0K | 0.00% | −1,073−8.1% | Reduced |
| State of Wyoming | 11,208 | $23.2K | 0.00% | +11,208 | New |
| Morgan Stanley | 6,112 | $12.7K | 0.00% | −189−3.0% | Reduced |
| Barclays PLC | 5,931 | $12.3K | 0.00% | +742+14.3% | Added |
| JPMorgan Chase & Co | 5,379 | $11.8K | 0.00% | −300−5.3% | Reduced |